Sergio Traversa

CEO at Relmada Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Relmada Therapeutics Inc., 3 years.

Relmada Therapeutics Inc. Director · Chief Executive Officer
3 years · Since 2023

Chief executive roles

Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 10, 2026 Relmada Therapeutics Inc. Open-market purchase +100,000 $4.10 $410,000
Sep 9, 2026 Relmada Therapeutics Inc. Open-market purchase +100,000 $4.18 $418,000
Dec 15, 2025 Relmada Therapeutics Inc. Open-market purchase +27,500 $4.12 $113,300
Nov 5, 2025 Relmada Therapeutics Inc. Open-market purchase +272,500 $2.20 $599,500
Aug 28, 2025 Relmada Therapeutics Inc. Open-market purchase +55,976 $0.74 $41,422
Aug 27, 2025 Relmada Therapeutics Inc. Open-market purchase +129,455 $0.67 $86,735
Aug 26, 2025 Relmada Therapeutics Inc. Open-market purchase +80,545 $0.62 $49,938
May 20, 2025 Relmada Therapeutics Inc. Open-market purchase +147,686 $0.56 $82,704
May 19, 2025 Relmada Therapeutics Inc. Open-market purchase +30,000 $0.50 $15,000
May 16, 2025 Relmada Therapeutics Inc. Open-market purchase +172,314 $0.45 $77,541
Sep 11, 2024 Relmada Therapeutics Inc. Open-market purchase +51,407 $2.99 $153,707
Sep 10, 2024 Relmada Therapeutics Inc. Open-market purchase +33,014 $2.75 $90,789
Sep 9, 2024 Relmada Therapeutics Inc. Open-market purchase +55,579 $2.71 $150,619
Jan 31, 2024 Relmada Therapeutics Inc. Open-market purchase +27,460 $4.00 $109,840
Jan 30, 2024 Relmada Therapeutics Inc. Open-market purchase +40,999 $3.90 $159,896

Questions about Sergio Traversa

What boards is Sergio Traversa on?

Sergio Traversa sits on the board of Relmada Therapeutics Inc.

What company is Sergio Traversa the CEO of?

Sergio Traversa is CEO of Relmada Therapeutics Inc.

How long has Sergio Traversa served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.